2023
A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibroblasts.
Clinical and translational medicine
•Research at a glance
Top areas of exploration
- Pancreatic Neoplasms , 46 publications
- Adenocarcinoma , 30 publications
- Postoperative Complications , 24 publications
- Pancreaticoduodenectomy , 20 publications
Research activity
Focus
Dr. Hughes' research interests center on improving the understanding of gastrointestinal tumor biology through genetic analysis and assessing the response of these historically stubborn tumors to a new class of medications called tyrosine kinase inhibitors.
My publications
Filter publications
173 publications
2023
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Future oncology (London, England)
•2023
A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma
Pancreatology
•2023
Addendum: Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Oncotarget
•2023
Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma.
Cancers
•